IL127701A0 - Hiv envelope polypeptides and vaccine - Google Patents

Hiv envelope polypeptides and vaccine

Info

Publication number
IL127701A0
IL127701A0 IL12770197A IL12770197A IL127701A0 IL 127701 A0 IL127701 A0 IL 127701A0 IL 12770197 A IL12770197 A IL 12770197A IL 12770197 A IL12770197 A IL 12770197A IL 127701 A0 IL127701 A0 IL 127701A0
Authority
IL
Israel
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
IL12770197A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL127701A0 publication Critical patent/IL127701A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12770197A 1996-07-08 1997-07-03 Hiv envelope polypeptides and vaccine IL127701A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67673796A 1996-07-08 1996-07-08
PCT/US1997/009690 WO1998001564A1 (fr) 1996-07-08 1997-07-03 Polypeptides d'enveloppe du hiv et vaccin

Publications (1)

Publication Number Publication Date
IL127701A0 true IL127701A0 (en) 1999-10-28

Family

ID=24715764

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12770197A IL127701A0 (en) 1996-07-08 1997-07-03 Hiv envelope polypeptides and vaccine
IL127701A IL127701A (en) 1996-07-08 1998-12-23 HIV gp 120 ENVELOPE POLYPEPTIDES, VACCINE AND METHODS FOR THEIR PREPARATION

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL127701A IL127701A (en) 1996-07-08 1998-12-23 HIV gp 120 ENVELOPE POLYPEPTIDES, VACCINE AND METHODS FOR THEIR PREPARATION

Country Status (13)

Country Link
US (1) US6090392A (fr)
EP (1) EP0942988A1 (fr)
JP (1) JP2000515368A (fr)
AP (1) AP1282A (fr)
AU (1) AU727107B2 (fr)
CA (1) CA2259965A1 (fr)
ID (1) ID17767A (fr)
IL (2) IL127701A0 (fr)
NZ (1) NZ333500A (fr)
OA (1) OA10954A (fr)
TW (1) TWI221846B (fr)
WO (1) WO1998001564A1 (fr)
ZA (1) ZA975889B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2903999A (en) 1998-03-12 1999-09-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
IL150961A0 (en) 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
WO2001083535A2 (fr) * 2000-05-02 2001-11-08 Simon Fraser University Peptides pouvant etre utilises en tant que vaccin et/ou traitement contre l'infection par hiv
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
AU2001291050A1 (en) 2000-09-15 2002-03-26 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Viral chemokine-tumur antigen fusion proteins
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
AU2003298912B2 (en) * 2002-12-03 2011-06-02 Advanced Bioscience Laboratories, Inc. Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods
WO2004110384A2 (fr) * 2003-06-12 2004-12-23 Vaxgen, Inc. Glycoproteines d'enveloppe du vih-1 a structure disulfure inhabituelle
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
DE602004030369D1 (de) * 2003-10-24 2011-01-13 Immunaid Pty Ltd Therapieverfahren
ES2383103T3 (es) * 2004-09-08 2012-06-18 Immunaid Pty Ltd Estrategia terapéutica para tratar enfermedades autoinmunitarias y degenerativas
CN101374550B (zh) * 2004-09-14 2013-05-15 阿戈斯治疗公司 病原体的非毒株依赖性扩增和针对其的疫苗
JP2009509970A (ja) * 2005-09-22 2009-03-12 プロサイ インコーポレイテッド 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
WO2009017743A2 (fr) 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Amorces et sondes améliorées pour l'amplification et la détection des polynucléotides gag, rev et nef du vih
CA2735724C (fr) 2008-06-19 2018-07-24 Variation Biotechnologies Inc. Compositions et procedes pour le traitement de la grippe
CA2763373C (fr) 2009-05-27 2018-01-09 Immunaid Pty Ltd Methodes et systemes permettant de determiner le moment prefere d'administration d'une therapie en vue de traiter des maladies
BR112012000826B1 (pt) 2009-07-06 2022-07-26 Variation Biotechnologies Inc Método para a preparação de vesículas
WO2011005772A1 (fr) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Procédés pour préparer des vésicules et formulations produites à partir de ces procédés
CA2793959C (fr) 2010-03-25 2019-06-04 Oregon Health & Science University Glycoproteines du cmv et vecteurs recombines
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
WO2012097346A1 (fr) 2011-01-13 2012-07-19 Variation Biotechnologies, Inc. Compositions et méthodes de traitement d'infections virales
EP2691530B1 (fr) 2011-06-10 2018-03-07 Oregon Health & Science University Glycoprotéines de cmv et vecteurs recombinants cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN104302323A (zh) 2012-01-12 2015-01-21 变异生物技术公司 用于治疗病毒感染的组合物和方法
AU2013213345A1 (en) 2012-01-27 2014-08-28 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
WO2014089152A1 (fr) 2012-12-04 2014-06-12 University Of Maryland, Baltimore Anticorps liant la protéine env du vih-1, protéines de fusion et leurs méthodes d'utilisation
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (fr) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Trimères de glycoprotéines d'enveloppe du vih -1 soluble
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
DE3855869T2 (de) * 1987-02-20 1997-10-02 Genentech Inc Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (fr) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Virus d'immunodéficience humaine (HIV) peptide env-codé capable de provoquer les anticorps inhibiteurs du HIV dans les mammifères
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
AU6523590A (en) * 1989-09-22 1991-04-18 Idec Pharmaceuticals Corporation Novel peptides associated with the cd4 binding region of gp120 and their methods of use
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
AU7676891A (en) * 1990-04-03 1991-10-30 Genentech Inc. Hiv envelope polypeptides
WO1994028929A1 (fr) * 1993-06-07 1994-12-22 Genentech, Inc. Polypeptides d'enveloppe du vih

Also Published As

Publication number Publication date
CA2259965A1 (fr) 1998-01-15
WO1998001564A1 (fr) 1998-01-15
AU3567797A (en) 1998-02-02
IL127701A (en) 2006-08-01
ZA975889B (en) 1998-02-23
TWI221846B (en) 2004-10-11
OA10954A (en) 2001-10-25
AP9901432A0 (en) 1999-03-31
JP2000515368A (ja) 2000-11-21
EP0942988A1 (fr) 1999-09-22
NZ333500A (en) 2000-09-29
ID17767A (id) 1998-01-22
AU727107B2 (en) 2000-11-30
US6090392A (en) 2000-07-18
AP1282A (en) 2004-06-09

Similar Documents

Publication Publication Date Title
AP9901432A0 (en) Hiv envelope polypeptides and vaccine
CZ20011341A3 (cs) Pomocné přípravky a vakciny
EP0708659A4 (fr) Polypeptides d'enveloppe du vih
EP0958364A4 (fr) Immunotherapie et vaccins perfectionnes
IL128985A0 (en) Vaccines
EP1021185A4 (fr) Dihydropyrimidines et leurs emplois
EP0958373A4 (fr) Vaccins
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
HU9701314D0 (en) Translucent ceramic and initial arc tube
GB9705903D0 (en) VP22 Proteins and uses thereof
HUP9701586A3 (en) Improved inactivated vaccines
EP0885293A4 (fr) Polypeptides de chemokine humaine
EP0750679A4 (fr) Peptides isoles derives de la tyrosinase et leurs utilisations
GB2331521B (en) Vaccine preparations
PL328334A1 (en) Preparation and application thereof
GB2336844B (en) Anti-hiv peptides and proteins
IL124430A0 (en) An envelope and an envelope construction
GB9625968D0 (en) Vaccine
IL115197A0 (en) Vaccine preparations
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
GB9609252D0 (en) Vaccines
GB9603322D0 (en) Viral preparations,immunogens and vaccines
GB9611334D0 (en) Viral antigens and their preparation
GB9703202D0 (en) HIV vaccine
GB9725241D0 (en) Hiv vaccine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed